Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Retatrutide is an investigational triple agonist (GLP-1, GIP, and glucagon receptors) not yet licensed by the MHRA or EMA, with Phase 2 data suggesting significant weight reduction but Phase 3 confirmation still required
Other compounds in this field include epitalon and thymalin
In a Cleveland Clinic study of patients who stopped a semaglutide (Ozempic, Wegovy) or tirzepatide (Zepbound) product, nearly half cited out-of-pocket cost as the primary reason
However, certain locations within refrigerators create cold spots where temperatures can drop below freezing
US$ 25.27
US$ 29.36
US$ 22.38
